Diana Baralle Selected Research

Diana Baralle Research Topics

Disease

7	Neoplasms (Cancer) 11/2021 - 08/2012
4	Breast Neoplasms (Breast Cancer) 11/2021 - 08/2012
3	Rare Diseases (Rare Disease) 09/2023 - 01/2021
3	COVID-19 01/2022 - 01/2021
2	Neurodevelopmental Disorders 04/2024 - 01/2020
2	Microcephaly 01/2021 - 01/2020
2	Growth Disorders 01/2019 - 04/2014
1	Fibrosis (Cirrhosis) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023
1	Malformations of Cortical Development 01/2023
1	Oculocutaneous albinism type 1 01/2022
1	Oculocutaneous albinism type 1B 01/2022
1	Human Influenza (Influenza) 01/2022
1	Septo-Optic Dysplasia 01/2022
1	Coloboma (Colobomas) 01/2022
1	Optic Atrophy 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Cataract (Cataracts) 01/2021
1	Infections 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Cleft Palate (Palate, Cleft) 01/2020
1	Anodontia (Hypodontia) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Megalencephaly 01/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020
1	Arthrogryposis 12/2019
1	Ciliopathies 11/2019
1	Sotos Syndrome 01/2019
1	Kabuki syndrome 01/2019
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2017
1	Ocular Albinism 01/2017
1	Albinism 01/2017
1	Intellectual Disability (Idiocy) 04/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 04/2014
1	Carcinogenesis 01/2012
1	King Denborough syndrome 06/2011
1	Muscular Diseases (Myopathy) 06/2011
1	Malignant Hyperthermia 06/2011
1	Central Core Myopathy (Central Core Disease) 06/2011
1	Vitelliform Macular Dystrophy 10/2004
1	Neurofibromatosis-Noonan syndrome 05/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2004
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
3	Protein Isoforms (Isoforms)IBA 11/2021 - 08/2012
3	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2014
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022 - 01/2017
2	Melanins (Melanin)IBA 01/2022 - 01/2017
2	RNA Precursors (Precursor, mRNA)IBA 11/2021 - 01/2020
1	Small Nuclear RNA (snRNA)IBA 04/2024
1	CollagenIBA 12/2023
1	Untranslated Regions (Untranslated Region)IBA 09/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	EnzymesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Initiator Codon (Start Codon)IBA 01/2022
1	CytokinesIBA 01/2022
1	VaccinesIBA 01/2022
1	Nucleosomes (Nucleosome)IBA 01/2022
1	NucleotidesIBA 01/2022
1	InterferonsIBA 01/2021
1	Coat Protein Complex I (COPI)IBA 01/2021
1	RNA Splicing FactorsIBA 01/2020
1	SpectrinIBA 01/2020
1	Retinaldehyde (Retinal)IBA 11/2019
1	DNA Methyltransferase 3AIBA 01/2019
1	Histone MethyltransferasesIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	BRCA1 ProteinIBA 01/2016
1	MethyltransferasesIBA 04/2014
1	Histones (Histone)IBA 04/2014
1	A-Form DNA (A-DNA)IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Trans-Activators (Trans-Acting Factor)IBA 01/2012
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2011
1	BestrophinsIBA 10/2004
1	Neurofibromin 1 (Neurofibromin)IBA 05/2003

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2017
1	Genomic Medicine 12/2020